Quality of Life Study With Adalimumab in Rheumatoid Arthritis
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the ability of adalimumab combined with methotrexate
to improve the quality of life in patients with active RA.